Shannon K Boi1, Claire M Buchta2, Nicole A Pearson3, Meghan B Francis4, David K Meyerholz5, Justin L Grobe3, Lyse A Norian6,7,8. 1. Graduate Biomedical Sciences, University of Alabama at Birmingham, Birmingham, Alabama, USA. 2. Department of Urology, The University of Iowa Carver College of Medicine, Iowa City, Iowa, USA. 3. Department of Pharmacology, The Obesity Research and Education Initiative, and the Fraternal Order of Eagles' Diabetes Research Center, The University of Iowa Carver College of Medicine, Iowa City, Iowa, USA. 4. Department of Nutrition Sciences, University of Alabama at Birmingham, Birmingham, Alabama, USA. 5. Department of Pathology, The University of Iowa Carver College of Medicine, Iowa City, Iowa, USA. 6. Graduate Biomedical Sciences, University of Alabama at Birmingham, Birmingham, Alabama, USA. lnorian@uab.edu. 7. Department of Nutrition Sciences, University of Alabama at Birmingham, Birmingham, Alabama, USA. lnorian@uab.edu. 8. Nutrition Obesity Research Center and Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, Alabama, USA. lnorian@uab.edu.
Abstract
OBJECTIVE: Diet-induced obesity has been shown to alter immune function in mice, but distinguishing the effects of obesity from changes in diet composition is complicated. It was hypothesized that immunological differences would exist between diet-induced obese (DIO) and obese-resistant (OB-Res) mice fed the same high-fat diet (HFD). METHODS: BALB/c mice were fed either standard chow or HFD to generate lean or DIO and OB-Res mice, respectively. Resulting mice were analyzed for serum immunologic and metabolic profiles and cellular immune parameters. RESULTS: BALB/c mice on HFD were categorized as DIO or OB-Res, based on body weight versus lean controls. DIO mice were physiologically distinct from OB-Res mice, whose serum insulin, leptin, gastric inhibitory polypeptide, and eotaxin concentrations remained similar to lean controls. DIO mice had increased macrophage(+) crown-like structures in white adipose tissue, although macrophage percentages were unchanged from OB-Res and lean mice. DIO mice also had decreased splenic CD4(+) T cells, elevated serum GM-CSF, and increased splenic CD11c(+) dendritic cells, but impaired dendritic cell stimulatory capacity (P < 0.05 vs. lean controls). These parameters were unaltered in OB-Res mice versus lean controls. CONCLUSIONS: Diet-induced obesity results in alterations in immune and metabolic profiles that are distinct from effects caused by HFD alone.
OBJECTIVE: Diet-induced obesity has been shown to alter immune function in mice, but distinguishing the effects of obesity from changes in diet composition is complicated. It was hypothesized that immunological differences would exist between diet-induced obese (DIO) and obese-resistant (OB-Res) mice fed the same high-fat diet (HFD). METHODS: BALB/c mice were fed either standard chow or HFD to generate lean or DIO and OB-Resmice, respectively. Resulting mice were analyzed for serum immunologic and metabolic profiles and cellular immune parameters. RESULTS: BALB/c mice on HFD were categorized as DIO or OB-Res, based on body weight versus lean controls. DIOmice were physiologically distinct from OB-Resmice, whose serum insulin, leptin, gastric inhibitory polypeptide, and eotaxin concentrations remained similar to lean controls. DIOmice had increased macrophage(+) crown-like structures in white adipose tissue, although macrophage percentages were unchanged from OB-Res and lean mice. DIOmice also had decreased splenic CD4(+) T cells, elevated serum GM-CSF, and increased splenic CD11c(+) dendritic cells, but impaired dendritic cell stimulatory capacity (P < 0.05 vs. lean controls). These parameters were unaltered in OB-Resmice versus lean controls. CONCLUSIONS: Diet-induced obesity results in alterations in immune and metabolic profiles that are distinct from effects caused by HFD alone.
Authors: J Justin Milner; Jenny Rebeles; Suraj Dhungana; Delisha A Stewart; Susan C J Sumner; Matthew H Meyers; Peter Mancuso; Melinda A Beck Journal: J Immunol Date: 2015-04-10 Impact factor: 5.422
Authors: Brian D Fink; Judith A Herlein; Deng Fu Guo; Chaitanya Kulkarni; Benjamin J Weidemann; Liping Yu; Justin L Grobe; Kamal Rahmouni; Robert J Kerns; William I Sivitz Journal: J Pharmacol Exp Ther Date: 2014-10-09 Impact factor: 4.030
Authors: Jane F Fearnside; Marc-Emmanuel Dumas; Alice R Rothwell; Steven P Wilder; Olivier Cloarec; Ayo Toye; Christine Blancher; Elaine Holmes; Roger Tatoud; Richard H Barton; James Scott; Jeremy K Nicholson; Dominique Gauguier Journal: PLoS One Date: 2008-02-27 Impact factor: 3.240
Authors: Anthony Cam; Ashley B Oyirifi; Yunxian Liu; Wanda M Haschek; Urszula T Iwaniec; Russell T Turner; Nicki J Engeseth; William G Helferich Journal: Cancer Prev Res (Phila) Date: 2019-03-18
Authors: Lauren Boland; Laura Melanie Bitterlich; Andrew E Hogan; James A Ankrum; Karen English Journal: Front Immunol Date: 2022-07-04 Impact factor: 8.786
Authors: William J Turbitt; Rachael M Orlandella; Justin T Gibson; Courtney M Peterson; Lyse A Norian Journal: Anticancer Res Date: 2020-10 Impact factor: 2.480
Authors: Kikumi D Ono-Moore; Jennifer M Rutkowsky; Nicole A Pearson; D Keith Williams; Justin L Grobe; Todd Tolentino; K C Kent Lloyd; Sean H Adams Journal: Am J Physiol Endocrinol Metab Date: 2020-07-21 Impact factor: 4.310
Authors: Vera Francisco; Jesús Pino; Victor Campos-Cabaleiro; Clara Ruiz-Fernández; Antonio Mera; Miguel A Gonzalez-Gay; Rodolfo Gómez; Oreste Gualillo Journal: Front Physiol Date: 2018-06-01 Impact factor: 4.566